Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain

Molecules

Volumn 18, Issue 9, 2013, Pages 10953-10972

  Alves, Luiz Anastacio ^a   Soares Bezerra, Rômulo José ^a   Faria, Robson Xavier ^a   Ferreira, Leonardo Gomes Braga ^a   Frutuoso, Valber Da Silva ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Antagonists and pharmacological target; Inflammatory response; P2X7R

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X7 RECEPTOR;

ANIMAL; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; NEURALGIA; NOCICEPTION; NOCICEPTIVE PAIN; PHYSIOLOGY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NEURALGIA; NOCICEPTION; NOCICEPTIVE PAIN; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7;

EID: 84885103040     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules180910953     Document Type: Review

References (125)

1. Sacca, R.; Cuff, C.A.; Ruddle, N.H. Mediators of inflammation. Curr. Opin. Immunol. 1997, 9, 851-857. (Pubitemid 28062271)
2. Ji, J.Y.; Jing, H.; Diamond, S.L. Hemodynamic regulation of inflammation at the endothelialneutrophil interface. Ann. Biomed. Eng. 2008, 36, 586-595.
3. Rojas-Dotor, S.; Perez-Ramos, J.; Rico-Rosillo, M.G. Chemotaxis and disease. Rev. Méd. Inst. Mex. Seguro. Soc. 2009, 47, 51-56.
4. Lecut, C.; Frederix, K.; Johnson, D.M.; Deroanne, C.; Thiry, M.; Faccinetto, C.; Maree, R.; Evans, R.J.; Volders, P.G.; Bours, V.; Oury, C. P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation. J. Immunol. 2009, 183, 2801-2809.
5. Kronlage, M.; Song, J.; Sorokin, L.; Isfort, K.; Schwerdtle, T.; Leipziger, J.; Robaye, B.; Conley, P.B.; Kim, H.-C.; Sargin, S.; et al. Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci. Signal. 2010, doi:10.1126/scisignal.2000588.
6. Burnstock, G. Purinergic nerves. Pharmacol.Rev. 1972, 24, 509-581.
7. Burnstock, G. Purinergic receptors. J. Theor. Biol. 1976, 62, 491-503.
8. Burnstock, G.; Kennedy, C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen. Pharmacol. 1985, 16, 433-440. (Pubitemid 16250911)
9. North, R.A. Molecular physiology of P2X receptors. Physiol. Rev. 2002, 82, 1013-1067.
10. Soltoff, S.P.; McMillian, M.K.; Talamo, B.R. ATP activates a cation-permeable pathway in rat parotid acinar cells. Am. J. Physiol. 1992, 262, C934-C940.
11. Hurley, T.W.; Shoemaker, D.D.; Ryan, M.P. Extracellular ATP prevents the release of stored Ca2+ by autonomic agonists in rat submandibular gland acini. Am. J. Physiol. 1993, 265, C1472-C1478.
12. Gonzalez, F.A.; Ahmed, A.H.; Lustig, K.D.; Erb, L.; Weisman, G.A. Permeabilization of transformed mouse fibroblasts by 3'-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate and the desensitization of the process. J. Cell Physiol. 1989, 139, 109-115. (Pubitemid 19120277)
13. Erb, L.; Lustig, K.D.; Ahmed, A.H.; Gonzalez, F.A.; Weisman, G.A. Covalent incorporation of 3'-O-(4-benzoyl)benzoyl-ATP into a P2 purinoceptor in transformed mouse fibroblasts. J. Biol. Chem. 1990, 265, 7424-31.
14. Burnstock, G.; Knight, G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 2004, 240, 31-304. (Pubitemid 39539202)
15. Evans, R.J.; Lewis, C.; Buell, G.; Valera, S.; North, R.A.; Surprenant, A. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). Mol. Pharmacol. 1995, 48, 178-183.
16. Communi, D.; Robaye, B.; Boeynaems, J.M. Pharmacological characterization of the human P2Y11 receptor. Br. J. Pharmacol. 1999, 128, 1199-206.
17. Surprenant, A.; Rassendren, F.; Kawashima, E.; North, R.A.; Buell, G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science. 1996, 272, 735-738.
18. Nuttle, L.C.; el-Moatassim, C.; Dubyak, G.R. Expression of the pore-forming P2Z purinoreceptor in Xenopus oocytes injected with poly(A)+ RNA from murine macrophages. Mol. Pharmacol. 1993, 44, 93-101. (Pubitemid 23230464)
19. Donnelly-Roberts, D.L.; Namovic, M.T.; Han, P.; Jarvis, M.F. Mammalian P2X7 receptor pharmacology: Comparison of recombinant mouse, rat and human P2X7 receptors. Br. J. Pharmacol. 2009, 157, 1203-1214.
20. Abbracchio, M.P.; Boeynaems, J.M.; Barnard, E.A.; Boyer, J.L.; Kennedy, C.; Miras-Portugal, M.T.; King, B.F.; Gachet, C.; Jacobson, K.A.; Weisman, G.A.; et al. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends. Pharmacol. Sci. 2003, 24, 52-55. (Pubitemid 36135872)
21. Szczepanska-Konkel, M.; Jankowski, M.; Stiepanow-Trzeciak, A.; Angielski, S. Effects of diadenosine polyphosphates on glomerular volume. Br. J. Pharmacol. 2005, 144, 1109-1117. (Pubitemid 40593009)
22. Virginio, C.; Church, D.; North, R.A.; Surprenant, A. Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology 1997, 36, 1285-94. (Pubitemid 27465616)
23. Acuña-Castillo, C.C.C.; Bull, P.; Brito, J.; Huidobro-Toro, J.P. Differential role of extracellular histidines in copper, zinc, magnesium and proton modulation of the P2X7purinergic receptor. J. Neurochem. 2007, 101, 17-26. (Pubitemid 46426467)
24. Liu, X.; Surprenant, A.; Mao, H.J.; Roger, S.; Xia, R.; Bradley, H.; Jiang, L.H. Identification of key residues coordinating functional inhibition of P2X7 receptors by zinc and copper. Mol. Pharmacol. 2008, 73, 252-259. (Pubitemid 350294216)
25. Coddou, C.; Yan, Z.; Obsil, T.; Huidobro-Toro, J.P.; Stojilkovic, S.S. Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev. 2011, 63, 641-683.
26. Jacobson, K.A.; Michael, F.J.; Michael, W. Purine and pyrimidine (P2) receptors as drug targets. J. Med. Chem. 2002, 45, 4057-4093. (Pubitemid 35025559)
27. Jiang, L.H.; Mackenzie, A.B.; North, R.A.; Surprenant, A. Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol. Pharmacol. 2000, 58, 82-88. (Pubitemid 30452530)
28. Jo, Y.H.; Donier, E.; Martinez, A.; Garret, M.; Toulme, E.; Boue-Grabot, E. Cross-talk between P2X4 and gamma-aminobutyric acid, type A receptors determines synaptic efficacy at a central synapse. J. Biol. Chem. 2011, 286, 19993-20004.
29. Nuttle, L.C.; Dubyak, G.R. Differential activation of cation channels and non-selective pores by macrophage P2z purinergic receptors expressed in Xenopus oocytes. J. Biol. Chem. 1994, 269, 13988-13996.
30. Gargett, C.E.; Wiley, J.S. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br. J. Pharmacol. 1997, 120, 1483-1490. (Pubitemid 27192439)
31. Murgia, M.; Hanau, S.; Pizzo, P.; Rippa, M.; Di, V.F. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 1993, 268, 8199-8203. (Pubitemid 23120407)
32. Chessell, I.P.; Michel, A.D.; Humphrey, P.P. Effects of antagonists at the human recombinant P2X7 receptor. Br. J. Pharmacol. 1998, 124, 1314-1320. (Pubitemid 28333958)
33. Michel, A.D.; Chessell, I.P.; Humphrey, P.P. Ionic effects on human recombinant P2X7 receptor function. Naunyn Schmiedebergs Arch. Pharmacol. 1999, 359, 102-109. (Pubitemid 29142878)
34. Humphreys, B.D.; Virginio, C.; Surprenant, A.; Rice, J.; Dubyak, G.R. Isoquinolines as antagonists of the P2X7 nucleotide receptor: High selectivity for the human versus rat receptor homologues. Mol. Pharmacol. 1998, 54, 22-32. (Pubitemid 28337583)
35. Shemon, A.N.; Sluyter, R.; Conigrave, A.D.; Wiley, J.S. Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor. Br. J. Pharmacol. 2004, 142, 1015-1019. (Pubitemid 39037051)
36. da Silva, C.M.; Rodrigues, L.M.; da Silva Gomes, A.P.; Barradas, M.M.; Vieira, F.S.; Persechini, P.M.; Coutinho-Silva, R. Modulation of P2X7 receptor expression in macrophages from mineral oil-injected mice. Immunobiology 2008, 213, 481-492.
37. Said, T.; Dutot, M.; Christon, R.; Beaudeux, J.L.; Martin, C.; Warnet, J.M.; Rat, P. Benefits and side effects of different vegetable oil vectors on apoptosis, oxidative stress, and P2X7 cell death receptor activation. Invest. Ophthalmol. Vis. Sci. 2007, 48, 5000-5006. (Pubitemid 351260909)
38. Liu, L.; Zou, J.; Liu, X.; Jiang, L.H.; Li, J. Inhibition of ATP-induced macrophage death by emodin via antagonizing P2X7 receptor. Eur. J. Pharmacol.2010, 640, 15-19.
39. Santos, J.A.; Fidalgo-Neto, A.A.; Faria, R.X.; Simoes, A.; Calheiros, A.S.; Berenger, A.L.; Faria-Neto, H.C.; Figueiredo, M.R.; Frutuoso, V.S.; Alves, L.A. Effect of Rheedia longifolia leaf extract and fractions on the P2X(7) receptor in vitro: Novel antagonists? J. Med. Food 2011, 14, 920-929.
40. Marques-da-Silva, C.; Chaves, M.M.; Castro, N.G.; Coutinho-Silva, R.; Guimaraes, M.Z. Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action. Br. J. Pharmacol. 2011, 163, 912-926.
41. Faria, R.; Ferreira, L.; Bezerra, R.; Frutuoso, V.; Alves, L. Action of natural products on p2 receptors: A reinvented era for drug discovery. Molecules 2012, 17, 13009-13025.
42. Soares-Bezerra, R.J.; Calheiros, A.S.; Ferreira, N.C.S.; Frutuoso, V.S.; Alves, L.A. Natural products as a source for new anti-inflammatory and analgesic compounds through the inhibition of purinergic P2X receptors. Pharmaceuticals 2013, 6, 650-658.
43. Buell, G.; Chessell, I.P.; Michel, A.D.; Collo, G.; Salazzo, M.; Herren, S.; Gretener, D.; Grahames, C.; Kaur, R.; Kosco-Vilbois, M.H.; et al. Blockade of human P2X7 receptor function with a monoclonal antibody. Blood 1998, 92, 3521-3528. (Pubitemid 28525175)
44. Kim, M.; Jiang, L.H.; Wilson, H.L.; North, R.A.; Surprenant, A. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 2001, 20, 6347-6358. (Pubitemid 33078708)
45. Chen, X.; Pierce, B.; Naing, W.; Grapperhaus, M.L.; Phillion, D.P. Discovery of 2-chloro-N- ((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5- fluoropyrimidin-2-yl)b enzamide as a potent and CNS penetrable P2X7 receptor antagonist. Bioorg. Med. Chem. Lett. 2010, 20, 3107-3111.
46. Chambers, L.J.; Stevens, A.J.; Moses, A.P.; Michel, A.D.; Walter, D.S.; Davies, D.J.; Livermore, D.G.; Fonfria, E.; Demont, E.H.; Vimal, M.; et al. Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor. Bioorg. Med. Chem. Lett. 2010, 20, 3161-3164.
47. Gleave, R.J.; Beswick, P.J.; Brown, A.J.; Giblin, G.M.; Goldsmith, P.; Haslam, C.P.; Mitchell, W.L.; Nicholson, N.H.; Page, L.W.; Patel, S.; et al. Synthesis and evaluation of 3-amino-6-arylpyridazines as selective CB(2) agonists for the treatment of inflammatory pain. Bioorg. Med. Chem. Lett. 2010, 20, 465-468.
48. Honore, P.; Donnelly-Roberts, D.; Namovic, M.; Zhong, C.; Wade, C.; Chandran, P.; Zhu, C.; Carroll, W.; Perez-Medrano, A.; Iwakura, Y.; et al. The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice. Behav. Brain Res. 2009, 204, 77-81.
49. Friedle, S.A.; Brautigam, V.M.; Nikodemova, M.; Wright, M.L.; Watters, J.J. The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia. Glia 2011, 59, 1-13.
50. Gunosewoyo, H.; Kassiou, M. P2X purinergic receptor ligands: Recently patented compounds. Expert Opin. Ther. Pat. 2010, 20, 625-646.
51. North, R.A.; Jarvis, M.F. P2X receptors as drug targets. Mol. Pharmacol. 2012, 83, 759-769.
52. Honore, P.; Donnelly-Roberts, D.; Namovic, M.T.; Hsieh, G.; Zhu, C.Z.; Mikusa, J.P.; Hernandez, G.; Zhong, C.; Gauvin, D.M.; Chandran, P.; et al. A-740003 [N-(1-{[(cyanoimino)(5- quinolinylamino)methyl]amino}-2,2- dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J. Pharmacol. Exp. Ther. 2006, 319, 1376-1385.
53. Stokes, L.; Jiang, L.H.; Alcaraz, L.; Bent, J.; Bowers, K.; Fagura, M.; Furber, M.; Mortimore, M.; Lawson, M.; Theaker, J.; et al. Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. Br. J. Pharmacol. 2006, 149, 880-887. (Pubitemid 44851712)
54. Yan, Z.; Khadra, A.; Li, S.; Tomic, M.; Sherman, A.; Stojilkovic, S.S. Experimental characterization and mathematical modeling of P2X7 receptor channel gating. J. Neurosci 2010, 30, 14213-14224.
55. Carroll, W.A.; Donnelly-Roberts, D.; Jarvis, M.F. Selective P2X(7) receptor antagonists for chronic inflammation and pain. Purinergic Signal. 2009, 5, 63-73.
56. Friedle, S.A.; Curet, M.A.; Watters, J.J. Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation. Recent Pat. CNS Drug Discov. 2010, 5, 35-45.
57. Volonte, C.; Apolloni, S.; Skaper, S.D.; Burnstock, G. P2X7 receptors: Channels, pores and more. CNS Neurol. Disord. Drug Targets 2012, 11, 705-721.
58. Jacob, F.; Novo, C.P.; Bachert, C.; Van Crombruggen, K. Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal. 2013, doi:10.1007/s11302-013-9357-4.
59. Lister, M.F.; Sharkey, J.; Sawatzky, D.A.; Hodgkiss, J.P.; Davidson, D.J.; Rossi, A.G.; Finlayson, K. The role of the purinergic P2X7 receptor in inflammation. J. Inflamm. (Lond.) 2007, 4, 542-548.
60. Smith, R.A.; Alvarez, A.J.; Estes, D.M. The P2X7 purinergic receptor on bovine macrophages mediates mycobacterial death. Vet. Immunol. Immunopathol. 2001, 78, 249-262. (Pubitemid 32243945)
61. Loomis, W.H.; Namiki, S.; Ostrom, R.S.; Insel, P.A. Hypertonic stress increases T cells interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation. J. Biol. Chem. 2003, 278, 4590-4596. (Pubitemid 36800956)
62. Mehta, V.B.; Hart, J.; Wewers, M.D. ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem. 2001, 276, 3820-3826.
63. Sluyter, R.; Barden, J.A.; Wiley, J.S. Detection of P2X purinergic receptors on human B lymphocytes. Cell. Tissue Res. 2001, 304, 231-236. (Pubitemid 32448989)
64. Bulanova, E.; Budagian, V.; Orinska, Z.; Hein, M.; Petersen, F.; Thon, L.; Adam, D.; Bulfone-Paus, S. Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. J. Immunol. 2005, 174, 3880-3890. (Pubitemid 40395960)
65. Chessell, I.P.; Hatcher, J.P.; Bountra, C.; Michel, A.D.; Hughes, J.P.; Green, P.; Egerton, J.; Murfin, M.; Richardson, J.; Peck, W.L.; et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114, 386-396. (Pubitemid 40385877)
66. Gabel, C.A. P2 purinergic receptor modulation of cytokine production. Purinergic Signal. 2007, doi:10.1007/s11302-006-9034-y.
67. Mingam, R.; De Smedt, V.; Amedee, T.; Bluthe, R.M.; Kelley, K.W.; Dantzer, R.; Laye, S. In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1 beta in the murine brain. Brain Behav. Immun. 2008, 22, 234-244.
68. Chiao, C.W.; Tostes, R.C.; Webb, R.C. P2X7 receptor activation amplifies lipopolysaccharideinduced vascular hyporeactivity via interleukin-1 beta release. J. Pharmacol. Exp. Ther. 2008, 326, 864-870.
69. Csolle, C.; Sperlagh, B. Peripheral origin of IL-1beta production in the rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X(7) receptors. J. Neuroimmunol. 2010, 219, 38-46.
70. Marques-da-silva, C.; Burnstock, G.; Ojcius, D.M.; Coutinho-silva, R. Immunobiology purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. Auton Neurosci. 2011, 216, 1-11.
71. Müller, T.; Vieira, R.P.; Grimm, M.; Dürk, T.; Cicko, S.; Zeiser, R.; Jakob, T.; Martin, S.F.; Blumenthal, B.; Sorichter, S.; et al. A potential role for P2X7R in allergic airway inflammation in mice and humans. Am. J. Respir. Cell Mol. Biol. 2011, 44, 456-464.
72. Furlan-Freguia, C.; Marchese, P.; Gruber, A.; Ruggeri, Z.M.; Ruf, W. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J. Clin. Invest.2011, 121, 2932-2944.
73. Elliott, M.R.; Chekeni, F.B.; Trampont, P.C.; Lazarowski, E.R.; Kadl, A.; Walk, S.F.; Park, D.; Woodson, R.I.; Ostankovich, M.; Sharma, P.; et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461, 282-286.
74. Pfeiffer, Z.A.; Aga, M.; Prabhu, U.; Watters, J.J.; Hall, D.J.; Bertics, P.J. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J. Leukoc. Biol. 2004, 75, 1173-1182. (Pubitemid 38720662)
75. Watters, J.J.; Sommer, J.A.; Fisette, P.L.; Pfeiffer, A.Z.; Aga, M.; Prabhu, U.; Guerra, A.N.; Denlinger, L.C.; Bertics, P.J. P2X7 nucleotide receptor: Modulation of LPS-induced macrophage signaling and mediator production. Drug Develop. Res. 2001, 53, 91-104. (Pubitemid 32845848)
76. Wesselius, A.; Bours, M.J.; Henriksen, Z.; Syberg, S.; Petersen, S.; Schwarz, P.; Jorgensen, N.R.; van Helden, S.; Dagnelie, P.C. Association of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients. Osteoporos. Int. 2013, 24, 1235-1246.
77. Toulme, E.; Tsuda, M.; Khakh, B.S.; Inoue, K. On the role of ATP-Gated P2X receptors in acute, inflammatory and neuropathic pain. In Translational Pain Research: From Mouse to Man; Kruger, L., Light, A.R., Eds.; CRC Press: Boca Raton, FL, USA, 2010.
78. Arulkumaran, N.; Unwin, R.J.; Tam, F.W. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert. Opin. Investig. Drugs 2011, 20, 897-915.
79. Al-Shukaili, A.; Al-Kaabi, J.; Hassan, B. A comparative study of interleukin-1beta production and p2x7 expression after ATP stimulation by peripheral blood mononuclear cells isolated from rheumatoid arthritis patients and normal healthy controls. Inflammation 2008, 31, 84-90. (Pubitemid 351388891)
80. Labasi, J.M.; Petrushova, N.; Donovan, C.; McCurdy, S.; Lira, P.; Payette, M.M.; Brissette, W.; Wicks, J.R.; Audoly, L.; Gabel, C.A. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 2002, 168, 6436-6445. (Pubitemid 34620068)
81. Portales-Cervantes, L.; Nino-Moreno, P.; Doniz-Padilla, L.; Baranda-Candido, L.; Garcia-Hernandez, M.; Salgado-Bustamante, M.; Gonzalez-Amaro, R.; Portales-Perez, D. Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. Hum. Immunol. 2010, 71, 818-825.
82. Portales-Cervantes, L.; Nino-Moreno, P.; Salgado-Bustamante, M.; Garcia-Hernandez, M.H.; Baranda-Candido, L.; Reynaga-Hernandez, E.; Barajas-Lopez, C.; Gonzalez-Amaro, R.; Portales-Perez, D.P. The His155Tyr (489C > T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2X7 receptor in immune cells from patients with rheumatoid arthritis. Cell Immunol. 2012, 276, 168-175.
83. Stock, T.C.; Bloom, B.J.; Wei, N.; Ishaq, S.; Park, W.; Wang, X.; Gupta, P.; Mebus, C.A. Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate. J. Rheumatol.2012, 39, 720-727.
84. Keystone, E.C.; Wang, M.M.; Layton, M.; Hollis, S.; McInnes, I.B.; Team, D.C.S. Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. Ann. Rheum. Dis. 2012, 71, 1630-1635.
85. Kobayashi, K.; Takahashi, E.; Miyagawa, Y.; Yamanaka, H.; Noguchi, K. Induction of the P2X7 receptor in spinal microglia in a neuropathic pain model. Neuro. Sci. Lett. 2011, 504, 57-61.
86. Skaper, S.D.; Debetto, P.; Giusti, P. P2X(7) Receptors in Neurological and Cardiovascular Disorders. Cardiovasc. Psychiatry Neurol. 2009, 2009, 861324-861324.
87. Klaumann, P.R.; Sillas T. Pathophysiology of pain. Arch. Vet. Sci. 2008, 13, 1-12.
88. Burgess, P.R.; Perl, E.R. Myelinated afferent fibres responding specifically to noxious stimulation of the skin. J. Physiol.1967, 190, 541-562.
89. Millan, M.J. The induction of pain: an integrative review. Prog. Neurobiol. 1999, 57, 1-164. (Pubitemid 28551764)
90. George, A.; Schneider-Gold, C.; Zier, S.; Reiners, K.; Sommer, C. Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch. Neurol. 2004, 61, 1938-1942. (Pubitemid 39612956)
91. Cregg, R.; Momin, A.; Rugiero, F.; Wood, J.N.; Zhao, J. Pain channelopathies. J. Physiol. 2010, 588, 1897-1904.
92. Collier, H.O.; James, G.W.; Schneider, C. Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5'- triphosphate. Nature 1966, 212, 411-412.
93. Bleehen, T.; Hobbiger, F.; Keele, C.A. Identification of algogenic substances in human erythrocytes. J. Physiol. 1976, 262, 131-149.
94. Fields, R.D.; Burnstock, G. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 2006, 7, 423-436. (Pubitemid 44012283)
95. Burnstock, G.; Campbell, G.; Satchell, D.; Smythe, A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. 1970. Br. J. Pharmacol. 1997, 120, 337-57.
96. Burnstock, G. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future. Bioessays 2012, 34, 218-225.
97. Zhou, Z.H.; Wang, J.X.; Liu, B.J.; Li, M.; Lu, Y.; Chen, H.S. Contribution of the spinal P2X7 receptors to bee venom-induced nociception and inflammation in conscious rats. Neurosci. Lett. 2012, 531, 145-148.
98. Scemes, E.; Giaume, C. Astrocyte calcium waves: What they are and what they do. Glia 2006, 54, 716-725. (Pubitemid 44629634)
99. Kushnir, R.; Cherkas, P.S.; Hanani, M. Peripheral inflammation upregulates P2X receptor expression in satellite glial cells of mouse trigeminal ganglia: A calcium imaging study. Neuropharmacology 2011, 61, 739-746.
100. Khakpay, R.; Polster, D.; Koles, L.; Skorinkin, A.; Szabo, B.; Wirkner, K.; Illes, P. Potentiation of the glutamatergic synaptic input to rat locus coeruleus neurons by P2X7 receptors. Purinergic signal. 2010, 6, 349-359.
101. Marchand, F.; Perretti, M.; McMahon, S.B. Role of the immune system in chronic pain. Nat. Rev. Neurosci. 2005, 6, 521-532. (Pubitemid 40942819)
102. Barrot, M. Tests and models of nociception and pain in rodents. Neuroscience 2012, 211, 39-50.
103. Itoh, K.; Chiang, C.Y.; Li, Z.; Lee, J.C.; Dostrovsky, J.O.; Sessle, B.J. Central sensitization of nociceptive neurons in rat medullary dorsal horn involves purinergic P2X7 receptors. Neuroscience 2011, 192, 721-731.
104. Hains, B.C.; Waxman, S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 2006, 26, 4308-4317. (Pubitemid 44315390)
105. Chang, Y.W.; Waxman, S.G. Minocycline attenuates mechanical allodynia and central sensitization following peripheral second-degree burn injury. J. Pain Relief. 2010, 11, 1146-1154.
106. Chiang, C.Y.; Zhang, S.; Xie, Y.F.; Hu, J.W.; Dostrovsky, J.O.; Salter, M.W.; Sessle, B.J. Endogenous ATP involvement in mustard-oil-induced central sensitization in trigeminal subnucleus caudalis (medullary dorsal horn). J. Neurophysiol. 2005, 94, 1751-1760. (Pubitemid 41192847)
107. Dell'Antonio, G.; Quattrini, A.; Cin, E.D.; Fulgenzi, A.; Ferrero, M.E. Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP. Arthritis Rheum. 2002, 46, 3378-3385. (Pubitemid 35453550)
108. Moalem, G.; Tracey, D.J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. 2006, 51, 240-264. (Pubitemid 43902971)
109. Ferrari, D.; Chiozzi, P.; Falzoni, S.; Dal Susino, M.; Melchiorri, L.; Baricordi, O.R.; Di Virgilio, F. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 1997, 159, 1451-1458. (Pubitemid 127484125)
110. Di Virgilio, F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol. Sci. 2007, 28, 465-472.
111. Ryu, J.K.; McLarnon, J.G. Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease. Neuroreport 2008, 19, 1715-1719.
112. Weisman, G.A.; Camden, J.M.; Peterson, T.S.; Ajit, D.; Woods, L.T.; Erb, L. P2 receptors for extracellular nucleotides in the central nervous system: Role of P2X7 and P2Y(2) receptor interactions in neuroinflammation. Mol. Neurobiol. 2012, 46, 96-113.
113. Jensen, T.S.; Baron, R.; Haanpaa, M.; Kalso, E.; Loeser, J.D.; Rice, A.S.; Treede, R.D. A new definition of neuropathic pain. Pain 2011, 152, 2204-2205.
114. McGaraughty, S.; Chu, K.L.; Namovic, M.T.; Donnelly-Roberts, D.L.; Harris, R.R.; Zhang, X.F.; Shieh, C.C.; Wismer, C.T.; Zhu, C.Z.; Gauvin, D.M.; et al. P2X7-related modulation of pathological nociception in rats. Neuroscience 2007, 146, 1817-1828. (Pubitemid 46783230)
115. Zhang, X.F.; Han, P.; Faltynek, C.R.; Jarvis, M.F.; Shieh, C.C. Functional expression of P2X7 receptors in non-neuronal cells of rat dorsal root ganglia. Brain Res. 2005, 1052, 63-70. (Pubitemid 41116288)
116. Chen, Y.W.; Donnelly-Roberts, D.L.; Namovic, M.T.; Gintant, G.A.; Cox, B.F.; Jarvis, M.F.; Harris, R.R. Pharmacological characterization of P2X7 receptors in rat peritoneal cells. Inflamm. Res. 2005, 54, 119-126. (Pubitemid 40767559)
117. Sorge, R.E.; Trang, T.; Dorfman, R.; Smith, S.B.; Beggs, S.; Ritchie, J.; Austin, J.S.; Zaykin, D.V.; Meulen, H.V.; Costigan, M.; et al. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat. Med.2012, 18, 595-599.
118. Hansen, R.R.; Nielsen, C.K.; Nasser, A.; Thomsen, S.I.; Eghorn, L.F.; Pham, Y.; Schulenburg, C.; Syberg, S.; Ding, M.; Stojilkovic, S.S.; et al. P2X7 receptor-deficient mice are susceptible to bone cancer pain. Pain 2011, 152, 1766-1776.
119. Barbera-Cremades, M.; Baroja-Mazo, A.; Gomez, A.I.; Machado, F.; Di Virgilio, F.; Pelegrin, P. P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release. FASEB J. 2012, 26, 2951-2962.
120. Tsuda, M.; Kuboyama, K.; Inoue, T.; Nagata, K.; Tozaki-Saitoh, H.; Inoue, K. Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol. Pain 2009, 5, 28-34.
121. Savi, P.; Herbert, J.M. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin. Thromb. Hemost. 2005, 31, 174-183. (Pubitemid 40605192)
122. Jelassi, B.; Anchelin, M.; Chamouton, J.; Cayuela, M.L.; Clarysse, L.; Li, J.; Gore, J.; Jiang, L.H.; Roger, S. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors. Carcinogenesis 2013, 34, 1487-1496.
123. Soares-Bezerra, R.J.; Pinho, R.T.; Bisaggio, R.C.; Benévolo, T.C.A.; Alves, L.A. The Possible use of agonists for P2X7 receptor as a treatment for multidrug resistance in tuberculosis: A therapeutic approach. 2013, submitted for publication.
124. Zumla, A.; Raviglione, M.; Hafner, R.; von Reyn, C.F. Tuberculosis. N Engl J Med. 2013, 368, 745-755.
125. Fernando, S.L.; Saunders, B.M.; Sluyter, R.; Skarratt. K.K.; Goldberg, H.; Marks, G.B. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am J Respir Crit Care Med. 2007, 75, 360-366.